AUY922 Terminated Phase 2 Trials for Metastatic Disease / Adenocarcinoma of the Pancreas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01484860Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy